登录

Yizhen Intelligence Closes $15M Series A1 Funding Round

作者: Mailman 2020-08-19 16:46
奕诊智能
https://www.envive.cn
企业数据由 动脉橙 提供支持
多专科综合人工智能辅助诊疗系统研发商 | A轮 | 运营中
中国-上海
2020-08-19
融资金额:$1500万
弘励创投/VI Ventures
查看

According to 36Kr.com, AI healthcare company Yizhen Medical Consulting Co., Ltd ("Yizhen Intelligence") has recently completed the Series A1 financing of US$15 million, with participation from VI Ventures, Mingye Venture Capital and individual investor Yang Guoan. Mushi Capital served as the exclusive financial adviser of this round.


Based on the cloud platform, Yizhen Intelligence uses AI technology to collect clinical data for the convenience of users, including recording, analysis, and collection of a vast amount of patients' data and combine it with users' charts to generate consultation that is scientifically standardized, greatly simplifying the workflow.


With the development of telemedicine, Yizhen Intelligence has gradually formed a business model combining online with offline, mainly online at present.


The core product of Yizhen Intelligence is the multi-specialty integrated AI-assisted diagnosis and treatment system, which currently covers 12 major specialties of internal medicine. Based on the achievements of science and technology, Yi Diagnostic has analyzed a large number of medical record data and massive medical literature during the cooperation with top doctors. It has taken 14 years to develop a complete map of medical knowledge and a core algorithm for processing it.


Yizhen Intelligence has designed special systems for doctors, patients, nurses, and the management team. In addition to its flagship auxiliary treatment service, Yizhen Intelligence also launched a by-product – the AI-powered medical education platform to build a "virtual hospital" for trainee doctors to practice their skills. The number of medical records generated on the platform can reach several hundred million to one billion, which can help train grass-roots doctors and improve the quality of medical treatment.


>>>>

About VI Ventures


VI Ventures is a venture capital firm with a focus on investing in TMT and MedTech companies in China, the U.S., and Israel. The firm invests in early-stage cross border technology companies. As a boutique firm, it provides seed, venture, and growth-stage funding. 


>>>>

About Mushi Capital


Mushi Capital is a venture capital company aiming to provide strong financial support for entrepreneurs. It mainly invests in the fields of TMT, big consumption, big data, medical and healthcare, enterprise services, and others.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

新加坡医疗科技公司DocDoc完成1300万美元融资,优化以大数据和AI为核心的医疗交付服务平台

【首发】晶铸生物顺利完成A+轮融资,聚焦AI宫颈癌细胞学筛查系统方案

【首发】绪水互联完成数千万元A轮融资,助力医院高质量发展,落地上千家医院

获国内唯一视觉训练翻转镜注册证,博艾特发力儿童青少年眼健康管理

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Dizal Pharmaceuticals Raises $100M in New Round of Financing

2020-08-19
下一篇

DK MedTech Snags ¥100M in Series B+ Financing Round

2020-08-19